Celesta Capital’s Post

What a wonderful episode in the Complexity podcast by Santa Fe Institute! Looking forward to listening the next episodes. May we have more of these critical and deep conversations about the terms that are used to describe our technologies, separating intend from what it is not. https://lnkd.in/eUVhFAbw

Here is a clip from our new podcast! Cory Diederich, from In-Position Technologies, and I, chat about the difference between AMRs and AGVs. Listen to the full episode to hear us talk about this industry and other non-industry related topics. Find NOVAcast Ep. 5 on our YouTube Channel!

I fully appreciate the benefits of specifically identifying sepsis and being able to discriminate this from non-infectious triggers of an uncontrollable systemic inflammatory response, so that appropriate use of antimicrobials and/or other treatments can be initiated ASAP to improve outcomes. However, it is also important to realize that cumulative clinical research evidence suggests that both infectious and non-infectious diseases that lead to hospitalization with SIRS, "progress in a very similar manner". Therefore, a common treatment can very likely be used ASAP to help control SIRS in the early stages, regardless of the triggering event, to minimize greater tissue injury and organ dysfunction. A major contributor to SIRS damage is persistently elevated hyperactivated neutrophils which are not self-sufficiently cleared by macrophage-mediated phagocytosis. As such, these WBCs overreact releasing their chromatin extracellularly (known as extracellular traps) which can increase the risk of hypercoagulation of the blood, glycocalyx-endothelial vascular injury, shock, and DIC. Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS) https://lnkd.in/ePE-tk7b reviewed Sobczak et. al Identification of neutrophil extracellular traps in the blood of patients with systemic inflammatory response syndrome https://lnkd.in/e5XxH4qM Tomono et. al. 2013 Therefore, it seems imperative to help patients as soon as possible, once SIRS is first recognized and immediately put the patient on an extracorporeal whole blood purification therapy capable of helping patients remove potential pathogens and elevated levels of extracellular nuclear chromatin circulating in their blood that has a high affinity for heparin/heparan sulfate. Here is a therapy capable of doing this while a clinician is awaiting the results of other diagnostics to appropriately treat with antimicrobials and/or other drug treatments that may or may not be necessary in helping the patient recover beyond the use of drug-free covalently immobilized heparin blood purification. https://lnkd.in/gg4dzRB6.

🎧 Amplify recommends this insightful podcast! Dive into engaging discussions on safety, innovation and tech with SafetyVue founder Tim Wolter. Check it out: https://lnkd.in/ewRJU3_U

Please follow us at Electra Link, Inc. to see all the latest updates at Electra Link and to check out our new podcast. Lots of great things happening!

Organizations that are able to track the way technology is being leveraged are better placed to use it effectively. On the latest episode of Technology Podcast, we discuss one approach to surfacing the reality on the ground, tune in: https://ter.li/asgr8v Alexey Antônio Villas Bôas | Ken Mugrage | Camilla Crispim | Renan Martins

Exciting times ahead for Europe’s self storage industry. Automation is stepping in to fill some major gaps in service and accessibility, and platforms like Stora are helping break down language barriers and streamline operations—making self storage easier and more accessible than ever. In our latest podcast episode, Grant Daniel and I dive into how automation is reshaping the future of self storage across Europe. Watch the full episode now to get more expert tips for your self storage business: https://bit.ly/40oI9IV #SelfStorage

In the latest episode of the ION Markets Quick Takes podcast, the team discusses variation margin and the challenges that arise from a lack of standardization across CCPs. In a complex industry, one thing is clear...clearer practices are necessary. Give it a listen today.

In the latest episode of the ION Markets Quick Takes podcast, the team discusses variation margin and the challenges that arise from a lack of standardization across CCPs. In a complex industry, one thing is clear...clearer practices are necessary. Give it a listen today.

Have you heard the latest episode of The TfSE Podcast? In this episode, podcast host Tia Shelley talks to Dr Joshua Jiao, Analysis Manager at TfSE, about his work and the importance of data in the transport world. Listen here: https://ow.ly/avSf50StCFi